📍#IMARS2026 | @andrea_cocci and Marta Pezzoli presented preliminary data on a new type of collagenase, adding to the evolving discussion on Peyronie’s disease treatment.
Related IJIR paper: rdcu.be/cK594uXLJvXa
@ijir.bsky.social
@ijir.bsky.social📍#IMARS2026 | @andrea_cocci and Marta Pezzoli presented preliminary data on a new type of collagenase, adding to the evolving discussion on Peyronie’s disease treatment.
Related IJIR paper: rdcu.be/cK594uXLJvXa
@donwglee.bsky.socialToday is Peyronie's Disease Awareness Day. Around 1 in 11 men experience it - scar tissue causing curvature, pain, or difficulty with intercourse. It's treatable, and there's no reason to stay silent. #peyroniesdisease #andrology
@ijir.bsky.social📍#IMARS2026 | Prof. Alessandro Zucchi presented “Hyaluronic acid in Peyronie’s disease: when and how?”, discussing patient selection, timing and intralesional treatment strategies citing this IJIR paper: rdcu.be/NrryTPLsD7Fa
@ijir.bsky.social📍#IMARS2026 | Michele Rizzo presented “Ultrasound in Peyronie’s Disease: when and why?”, highlighting imaging in diagnosis, counselling and individualized PD management.
Related IJIR paper: rdcu.be/NrryTPLsD7Fa
@ijir.bsky.social📍#IMARS2026 | @castiglionfabio presented “New perspectives on definition and classification of Peyronie’s Disease,” highlighting clearer terminology and patient-centred classification in PD care.
Related IJIR paper: rdcu.be/PymC6wPefc3a
